[PDF] Top 20 Second-generation long-acting injectable antipsychotics in schizophrenia: patient functioning and quality of life
Has 10000 "Second-generation long-acting injectable antipsychotics in schizophrenia: patient functioning and quality of life" found on our website. Below are the top 20 most common "Second-generation long-acting injectable antipsychotics in schizophrenia: patient functioning and quality of life".
Second-generation long-acting injectable antipsychotics in schizophrenia: patient functioning and quality of life
... 24-month, rater-blinded, randomized controlled study found that time to relapse was significantly longer in patients on PP (n = 352) versus patients treated with antipsychotic monotherapy (n = 363). Significantly fewer ... See full document
13
The use of long acting injectable antipsychotic medication
... oral second generation antipsychotics which were once purported to be more efficacious further slowed down the use of first generation ...of second generation LAIs has seen ... See full document
9
Clinical Decision-Making in the Treatment of Schizophrenia: Focus on Long-Acting Injectable Antipsychotics
... of long-acting injectable (LAI) antipsychotics, as well as the information sources influencing medical decision-making about treatment of ...used second- generation antipsychotic ... See full document
9
Role of 3-monthly long-acting injectable paliperidone in the maintenance of schizophrenia
... European Long-Acting Antipsychotics in Schizophrenia Trial (EULAST), which compares oral and LAI formulations of aripiprazole and paliperidone ...performance, functioning, and ... See full document
13
Long-acting injectable risperidone in partially adherent and nonadherent patients with schizophrenia
... for schizophrenia; age 18–50 years; current treatment with oral antipsychotics (both first- and second- generation); history of nonadherence to antipsychotic treatment within the previous 12 ... See full document
8
<p>Patients’ Preference for Long-Acting Injectable versus Oral Antipsychotics in Schizophrenia: Results from the Patient-Reported Medication Preference Questionnaire</p>
... oral antipsychotics as a treatment ...LAI antipsychotics focused on achieving patient empowerment and quality-of-life-related ...personalized schizophrenia treatment for improved ... See full document
10
Head-to-head comparison of 1-year aripiprazole long-acting injectable (LAI) versus paliperidone LAI in comorbid psychosis and substance use disorder: impact on clinical status, substance craving, and quality of life
... the patient to remain under observation in a protected environment for further 3 hours, while newly approved for- mulations like aripiprazole lauroxil and PP 3 months have not been launched in all ... See full document
12
Treatment patterns and health care resource utilization in a 1-year observational cohort study of outpatients with schizophrenia at risk of nonadherence treated with long-acting injectable antipsychotics
... LAI second-generation antipsychotics that do not require an initial overlap with prior oral therapy are ...LAI antipsychotics also supports the opinion that the unavailability of other ... See full document
10
Current approaches to treatments for schizophrenia spectrum disorders, part I: an overview and medical treatments
... and second-generation antipsychotics on cognitive and social functioning, as well as other longer-term effects such as mortality and quality of life, are ...individual ... See full document
22
Targets, attitudes, and goals of psychiatrists treating patients with schizophrenia: key outcome drivers, role of quality of life, and place of long-acting antipsychotics
... “relationships/social functioning” and “recovered ...and long-term management of schizophrenia to identify treatments that can help patients lead a more fulfill- ing and satisfying life as a ... See full document
10
Impact of long-acting injectable antipsychotics on medication adherence and clinical, functional, and economic outcomes of schizophrenia
... Abstract: Schizophrenia is a debilitating chronic disease that requires lifelong medical care and ...oral antipsychotics is the most common cause of ...oral antipsychotics in schizophrenia ... See full document
10
<p>The modern perspective for long-acting injectables antipsychotics in the patient-centered care of schizophrenia</p>
... Abstract: Schizophrenia is a chronic syndrome involving different clinical dimensions, and causes signi fi cant disability with a negative impact on the quality of life of patients and their ...of ... See full document
16
<p>Patients’ experiences of long-acting injectable antipsychotics: a qualitative study</p>
... Long-acting injectable antipsychotics (LAIs) have been widely used in the modern treatment of various psychiatric disorders such as schizophrenia and bipolar ...were second ... See full document
8
Effects of long-acting injectable antipsychotics versus oral antipsychotics on autonomic nervous system activity in schizophrenic patients
... Therefore, in this study, we investigated the effects of four atypical antipsychotic drugs and three LAIs of atypical antipsychotics on ANS activity. We evaluated ANS activity noninvasively by assessing 5-minute ... See full document
6
Initiating/maintaining long-acting injectable antipsychotics in schizophrenia/schizoaffective or bipolar disorder – expert consensus survey part 2
... appropriate, second line as somewhat appropriate, and third line as ...with schizophrenia/ schizoaffective and bipolar disorders as well as their knowledge of research and/or published ...with ... See full document
18
The efficacy of Garcinia mangostana L. (mangosteen) pericarp as an adjunctive to second-generation antipsychotics for the treatment of schizophrenia: a double blind, randomised, placebo-controlled trial
... In schizophrenia, neuronal damage is likely to influence those synapses involved in memory storage that connect neurons for the exchange of electrical and chemical impulses (Mayford, Siegelbaum & Kandel ...in ... See full document
171
Discrepancy in Taiwanese psychiatrists’ preferences for long-acting injectable antipsychotics across facilities: a nationwide questionnaire survey
... the long-term control of schizophrenia, rather than as an acute ...oral antipsychotics for chronic patients who had had more than two psychotic ... See full document
5
Paliperidone extended-release: does it have a place in antipsychotic therapy?
... that second-generation antipsychotics are diverse and should not be seen as a homogenous ...first-generation antipsychotics, each second-generation antipsychotic needs to ... See full document
22
Haloperidol decanoate and long-acting injectable risperidone: subjective experience of outpatients with schizophrenia
... risperidone long acting abbiamo trovato una differente distribuzio- ne dell’età statisticamente significativa (p < 0,002) nell’intervallo tra i 26- 40 anni (0 ...iniettabile long acting ... See full document
6
Impact of atypical long acting injectable versus oral antipsychotics on rehospitalization rates and emergency room visits among relapsed schizophrenia patients: a retrospective database analysis
... AP long-acting injectable ther- apy (LAT) can significantly improve adherence, reduce symptoms, and reduce the risk of relapse and rehospi- talization, particularly for severely ill patients ...in ... See full document
11
Related subjects